Log In
BCIQ
Print this Print this
 

Actikerall, fluorouracil/salicylic acid (LAS41005)

  Manage Alerts
Collapse Summary General Information
Company Almirall S.A.
DescriptionFixed-dose combination of 0.5% 5-fluorouracil (5-FU) and 10% salicylic acid in a film-forming base
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationActinic keratosis
Indication DetailsTreat actinic keratosis lesions; Treat palpable and/or moderately thick hyperkeratotic actinic keratosis; Treat severe keratosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$0.4M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/06/2015

Undisclosed

$0.4M

Undisclosed

Get a free BioCentury trial today